HIV and AIDS in closed settings: Issues and Challenges (Dr. Fabienne Hariga, MPH)

Embed Size (px)

Citation preview

  • 8/7/2019 HIV and AIDS in closed settings: Issues and Challenges (Dr. Fabienne Hariga, MPH)

    1/13

    HIV AIDS SECTION

    HIV and AIDS in closed settings

    Issues and Challenges

    Journalist Global Media TrainingNational Press Foundations Journalist

    Vienna, 14 July 2010

    Dr Fabienne Hariga

    Global focal point for HIV in prisons

  • 8/7/2019 HIV and AIDS in closed settings: Issues and Challenges (Dr. Fabienne Hariga, MPH)

    2/13

    2

    30 million people incarcerated each year in prisonsonly;

    HIV prevalence in prison can be very up- to 65%;

    50-80% of deaths in prisons reported to be due to TB(WHO)

    Proportion ofIDUs, can be very high (80%)

    Number of drug users detained in C

    DTC?

  • 8/7/2019 HIV and AIDS in closed settings: Issues and Challenges (Dr. Fabienne Hariga, MPH)

    3/13

    3

    HIV prevalence in prison higher than in the

    community

    0%

    5%

    10%

    15%

    20%

    25%

    30%

    35%

    40%

    45%

    Mexico

    RussianF

    ederation

    Latvia

    Switzerland

    France

    Indonesia

    Spain

    Brazil

    Vietnam

    M

    orocco

    Cted'Ivoire

    SouthAfrica

    HIV Prevalence rates in general population and in prisons in selected countries

    General adult population

    Up-to in prison population

  • 8/7/2019 HIV and AIDS in closed settings: Issues and Challenges (Dr. Fabienne Hariga, MPH)

    4/13

    4

    HIV prevalence in

    women prison

    almost alwayshigher than in men

    prisons.

    0%

    5%

    10%

    15%

    20%

    25%

    30%

    BRAZ

    IL

    USA(CT

    )

    MOLD

    OVA

    INDIA

    PAKISTAN

    GABO

    N

    RWAN

    DASPAIN

    HIV prevalence rates in women / men prisons in selected countries

    HIV P rev Women in prison

    HIV prev Men in Prison

  • 8/7/2019 HIV and AIDS in closed settings: Issues and Challenges (Dr. Fabienne Hariga, MPH)

    5/13

    5

    HIV and HIV/TB in prison: contributing factors

    1. Criminal Justice /Legal framework: over-representation ofmostvulnerable population groups forHIV

    2. All modes of transmission occurring in the community, occur in prison:

    sexual transmission (consensual, forced)

    blood transmission (injecting drugs, tattooing, and nosocomialinfections (through health care), fights)

    vertical transmission: mother to child transmission

    3. Poor prison conditions: overcrowding, malnutrition, poor ventilation,hygiene

    4. Poorprison management: violence, gangs, corruption

    5. Low access to health care (preventive, curative, reproductive andpalliative) and weak or nonexistent linkages with public health sectorand NGOs

    6. Stigma and discrimination for PLWH, for detainees; for drug users ,MSM

    7. Denial & lack of interest

  • 8/7/2019 HIV and AIDS in closed settings: Issues and Challenges (Dr. Fabienne Hariga, MPH)

    6/13

    6

    Key elements to be addressed

    Introducing comprehensive HIV prevention,

    treatment & care

    Providing equivalent health care services to thosein the community

    Improving prison conditions and undertaking prison

    reforms

    Reducing prison population and undertaking

    criminal justice reforms

  • 8/7/2019 HIV and AIDS in closed settings: Issues and Challenges (Dr. Fabienne Hariga, MPH)

    7/13

    7

    A multi factorial issue requiring a multidisciplinary response

    Public Health

    Occupational health

    Criminal Justice

    Gender policies

    Human Rights

    Prison management

  • 8/7/2019 HIV and AIDS in closed settings: Issues and Challenges (Dr. Fabienne Hariga, MPH)

    8/13

    8

    Comprehensive HIV response (staff and

    prisoners) Access to information (IEC), peers prevention

    Access to Voluntary Counselling & Testing (VCT)

    Prevention, treatment of STIs and condoms programming

    Access to safe injection equipment, tattooing eq., Access to evidence-based drug dependence treatments

    including opioid substitution

    Access to ARV (Treatment, PEP, PMTC)

    Access to protective equipment (staff)

    Prevention ofsexual violence, conjugal visiting rooms

    Universal precaution

    Prevention and treatment ofTB and HIV/TB collaborative

  • 8/7/2019 HIV and AIDS in closed settings: Issues and Challenges (Dr. Fabienne Hariga, MPH)

    9/13

    9

    Dont do

    Mandatory HIV testing

    Segregation of PLWH

    Send people to prisons for so called treatment

  • 8/7/2019 HIV and AIDS in closed settings: Issues and Challenges (Dr. Fabienne Hariga, MPH)

    10/13

    10

    Challenges

    Overuse of imprisonment and underuse of alternatives Legal contexts

    Prison authorities are often isolated from other nationalhealth authorities such as M.o.H, drug control agencies,national AIDS councils, or CCM;

    Denial that HIV in prison is a problem, that transmissionoccur in prison

    Many authorities are concerned but lack of politic and publicinterest

    Health, tuberculosis and HIV in prison poorly funded

    Poorly represented in national AIDS strategies

    Poorly (not) included in GF proposals

  • 8/7/2019 HIV and AIDS in closed settings: Issues and Challenges (Dr. Fabienne Hariga, MPH)

    11/13

    11

    Some important Prison indicators

    Prison population rate: Number of prisoners / 100 000 hab.

    % pre-sentenced prisoners

    Occupancy rate

    Classification system: Women

    Children

    Pre-trial

    Proportion of drug users (MSM, Sexworkers)

    Prevalence HIV/TB/HCV/HBV Mortality rates

    HIV services available/coverage

  • 8/7/2019 HIV and AIDS in closed settings: Issues and Challenges (Dr. Fabienne Hariga, MPH)

    12/13

    12

    Remember !

    HIV in prisons: all regions are concerned

    UNODC programmes should address HIV/TB in

    prisons for all (and not only HIV and Drug users inprisons)

    There are many issues, many challenges but also

    opportunities!

  • 8/7/2019 HIV and AIDS in closed settings: Issues and Challenges (Dr. Fabienne Hariga, MPH)

    13/13

    13

    THANK YOU

    WWW.UNODC.ORG/AIDS